Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Status:
Terminated
Trial end date:
2016-10-05
Target enrollment:
Participant gender:
Summary
This is a Phase 1 open-label, dose-escalation trial using "3+3" design, evaluating MM-151
co-administration with MM-121, MM-141, and trametinib at varying dose levels.